FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
Autoimmune Diseases For Hashimoto’s thyroiditis (underactive thyroid), Graves’ disease (overactive thyroid), Lupus, Crohn's disease, all types of arthritis, and all other autoimmune diseases. [Multiple sclerosis (MS) and Myasthenia Gravis (MG) have their own forums below.] |
|
Thread Tools | Display Modes |
![]() |
#1 | |||
|
||||
Senior Member
|
"Trial Drug Clears Psoriasis Better Than Humira."
"According to clinical trial results published in July's New England Journal of Medicine, up to 45 percent of psoriasis patients taking a biologic called guselkumab had completely clear skin after four months." Read On here: https://www.psoriasis.org/advance/tr...er-than-humira NEJM Article on Guselkumab Trials: A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis http://www.nejm.org/doi/full/10.1056/NEJMoa1501646 Guselkumab is currently being tested in Phase 3 trials, thus not yet available by prescription. Psoriasis is a "systemic" disease with significant co-morbidities, including heart disease, diabetes and more. Patients with psoriasis skin lesions often benefit from immune modulation (or suppression) and the minimizing of systemic inflammation, etc. The goal of clearing lesions is just a part of the goal, as there are often underlying co-occurring conditions needing treatment as well. This is exciting news for many people suffering treatment-resistant Plaque Psoriasis. I hope this medication will truly be helpful to those suffering. ![]() To Our Healing, ![]() DejaVu |
|||
![]() |
![]() |
"Thanks for this!" says: | kiwi33 (08-01-2015) |
|
|
![]() |
||||
Thread | Forum | |||
? to you here with psoriasis | Multiple Sclerosis | |||
Promising Dyskinesia Drug in Trials | Parkinson's Disease | |||
pd and psoriasis? | Parkinson's Disease |